Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction

Circulation

Volumn 112, Issue 10, 2005, Pages 1451-1461

  Kraitchman, Dara L ^a,d   Tatsumi, Mitsuaki ^a   Gilson, Wesley D ^a   Ishimori, Takayoshi ^a   Kedziorek, Dorota ^a   Walczak, Piotr ^a   Segars, W Paul ^a   Chen, Hunter H ^a   Fritzges, Danielle ^a   Izbudak, Izlem ^a   Young, Randell G ^b   Marcelino, Michelle ^b   Pittenger, Mark F ^b   Solaiyappan, Meiyappan ^a   Boston, Raymond C ^c   Tsui, Benjamin M W ^a   Wahl, Richard L ^a   Bulte, Jeff W M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OSIRIS THERAPEUTICS INC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Magnetic resonance imaging; Myocardial infarction; Nuclear medicine; Radionuclide imaging; Stem cell

Indexed keywords

8 QUINOLINOL INDIUM IN 111; CONTRAST MEDIUM; SUPERPARAMAGNETIC IRON OXIDE; TRACER;

ALLOGENEIC MESENCHYMAL STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOG; DRUG UPTAKE; HEART INFARCTION; ISOTOPE LABELING; KIDNEY; LIVER; LUNG; MESENCHYME CELL; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOACTIVITY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLEEN; TIME SERIES ANALYSIS; VALIDATION PROCESS;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; DOGS; INDIUM RADIOISOTOPES; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; ORGANOMETALLIC COMPOUNDS; OXYQUINOLINE; REPRODUCIBILITY OF RESULTS; STEM CELLS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, HOMOLOGOUS;

EID: 24744434734     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.537480     Document Type: Article

References (46)

1. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430-436.
2. Bittner RE, Schofer C, Weipoltshammer K, Ivanova S, Streubel B, Hauser E, Freilinger M, Hoger H, Elbe-Burger A, Wachtler F. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl). 1999;199:391-396.
3. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schachinger V, Dimmeler S, Zeiher AM, Teupe C, Britten M, Dobert N, Grunwald F, Aicher A, Urbich C, Hoelzer D. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation. 2003; 108:2212-2218.
4. Bittira B, Shum-Tim D, Al-Khaldi A, Chiu RC. Mobilization and homing of bone marrow stromal cells in myocardial infarction. Eur J Cardiothorac Surg. 2003;24:393-398.
5. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001;98:10344-10349.
6. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg. 2002;73:1919-1925; discussion 1926.
7. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, Jia ZQ. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 1999;100(suppl):II247-II256.
8. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, Schneider MD. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003;100: 12313-12318.
9. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 2002;106:3009-3017.
10. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004; 364:141-148.
11. Deb A, Wang S, Skelding KA, Miller D, Simper D, Caplice NM. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation. 2003;107:1247-1249.
12. Bayes-Genis A, Salido M, Sole Ristol F, Puig M, Brossa V, Camprecios M, Corominas JM, Marinoso ML, Baro T, Vela MC, Serrano S, Padro JM, Bayes de Luna A, Cinca J. Host cell-derived cardiomyocytes in sex-mismatch cardiac allografts. Cardiovasc Res. 2002;56:404-410.
13. Muller P, Pfeiffer P, Koglin J, Schafers HJ, Seeland U, Janzen I, Urbschat S, Bohm M. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation. 2002;106:31-35.
14. Hruban RH, Long PP, Perlman EJ, Hutchins GM, Baumgartner WA, Baughman KL, Griffin CA. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol. 1993; 142:975-980.
15. Laflamme MA, Myerson D, Saffitz JE, Murry CE. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res. 2002;90:634-640.
16. Sauer H, Hescheler J, Wartenberg M. Cardiac differentiation of mesenchymal stem cells in sex mis-matched transplanted hearts: self-repair or just a visit? Cardiovasc Res. 2002;56:357-358.
17. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284: 143-147.
18. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93-98.
19. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cell Tissues Organs. 2001;169:12-20.
20. 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl Med Commun. 2003;24: 1149-1154.
21. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003;108:863-868.
22. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH Jr, Bulte JWM. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology. 2003;228:480-487.
23. Kraitchman DL, Heldman AW, Atalar E, Amado L, Martin BJ, Pittenger MF, Hare JM, Bulte JW. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003;107: 2290-2293.
24. Malich G, Markovic B, Winder C. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology. 1997;124:179-192.
25. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004;17:513-517.
26. Tsui BM, Gullberg GT, Edgerton ER, Ballard JG, Perry JR, McCartney WH, Berg J. Correction of nonuniform attenuation in cardiac SPECT imaging. J Nucl Med. 1989;30:497-507.
27. Frey EC, Tsui BMW. T. Modeling the scatter response function in inhomogeneous scattering media for SPECT. IEEE Trans Nucl Sci. 1994; 41:1585-1593.
28. Tsui BMW, Hu HB, Gilland DR, Gullberg GT. Implementation of simultaneous attenuation and detector response correction in SPECT. IEEE Trans Nucl Sci. 1988;NS-35:778-783.
29. Tsui BMW, Zhao XD, Frey EC, McCartney WH. Quantitative single-photon emission computed tomography: basics and clinical considerations. Semin Nucl Med. 1994;XXIV:38-65.
30. Kadrmas DJ, Frey EC, Karimi SS, Tsui BM. Fast implementations of reconstruction-based scatter compensation in fully 3D SPECT image reconstruction. Phys Med Biol. 1998;43:857-873.
31. Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging. 2003;2:131-137.
32. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, Mohan V, Becker LC, Zerhouni EA. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation. 1995;92:1902-1910.
33. Amado LC, Kraitchman DL, Gerber BL, Castillo E, Boston RC, Grayzel J, Lima JA. Reduction of "no-reflow" phenomenon by intra-aortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study. J Am Coll Cardiol. 2004;43:1291-1298.
34. Bulte JW, Arbab AS, Douglas T, Frank JA. Preparation of magnetically labeled cells for tracking by magnetic resonance imaging. Methods Enzymol. 2004;386:275-299.
35. 111Inlabeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med. 2004;45:512-518.
36. Kuyama J, McCormack A, George AJ, Heelan BT, Osman S, Batchelor JR, Peters AM. Indium-111 labelled lymphocytes: isotope distribution and cell division. Eur J Nucl Med. 1997;24:488-496.
37. Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, Assmus B, Eckey T, Henze E, Zeiher AM, Dimmeler S. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation. 2003;107:2134-2139.
38. Chisholm PM, Danpure HJ, Healey G, Osman S. Cell damage resulting from the labeling of rat lymphocytes and HeLa S3 cells with In-111 oxine. J Nucl Med. 1979;20:1308-1311.
39. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stern cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood. 2003;101:2999-3001.
40. Cui J, Wahl RL, Shen T, Fisher SJ, Recker E, Ginsburg D, Long MW. Bone marrow cell trafficking following intravenous administration. Br J Haematol. 1999;107:895-902.
41. Ciulla MM, Lazzari L, Pacchiana R, Esposito A, Bosari S, Ferrero S, Gianelli U, Paliotti R, Busca G, Giorgetti A, Magrini F, Rebulla P. Homing of peripherally injected bone marrow cells in rat after experimental myocardial injury. Haematologica. 2003;88:614-621.
42. Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J, Demarquay C, Cuvelier F, Mathieu E, Trompier F, Dudoignon N, Germain C, Mazurier C, Aigueperse J, Borneman J, Gorin NC, Gourmelon P, Thierry D. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med. 2003;5:1028-1038.
43. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004;95:9-20.
44. Thakur ML, Gottschalk A, Zaret BL. Imaging experimental myocardial infarction with indium-111-labeled autologous leukocytes: effects of infarct age and residual regional myocardial blood flow. Circulation. 1979;60:297-305.
45. Bulte JW, Kraitchman DL. Monitoring cell therapy using iron oxide MR contrast agents. Curr Pharm Biotechnol. 2004;5:567-584.
46. Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, Pessanha BS, Guttman MA, Varney TR, Martin BJ, Dunbar CE, McVeigh ER, Lederman RJ. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation. 2003;11:11.